205 related articles for article (PubMed ID: 28770399)
1. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator.
Alta RYP; Vitorino HA; Goswami D; Terêsa Machini M; Espósito BP
Biometals; 2017 Oct; 30(5):709-718. PubMed ID: 28770399
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.
Alta RY; Vitorino HA; Goswami D; Liria CW; Wisnovsky SP; Kelley SO; Machini MT; Espósito BP
PLoS One; 2017; 12(2):e0171729. PubMed ID: 28178347
[TBL] [Abstract][Full Text] [Related]
3. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
Lim CK; Kalinowski DS; Richardson DR
Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
[TBL] [Abstract][Full Text] [Related]
4. Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.
Alta EC; Goswami D; Machini MT; Silvestre DM; Nomura CS; Espósito BP
Biometals; 2014 Dec; 27(6):1351-60. PubMed ID: 25265871
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of hydroxamate-based iron chelators.
Bergeron RJ; Wiegand J; McManis JS; Perumal PT
J Med Chem; 1991 Nov; 34(11):3182-7. PubMed ID: 1956036
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture.
Sangchot P; Sharma S; Chetsawang B; Porter J; Govitrapong P; Ebadi M
Dev Neurosci; 2002; 24(2-3):143-53. PubMed ID: 12401952
[TBL] [Abstract][Full Text] [Related]
7. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
8. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron.
Richardson DR; Mouralian C; Ponka P; Becker E
Biochim Biophys Acta; 2001 May; 1536(2-3):133-40. PubMed ID: 11406348
[TBL] [Abstract][Full Text] [Related]
9. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1.
Choi EY; Park ZY; Choi EJ; Oh HM; Lee S; Choi SC; Lee KM; Im SH; Chun JS; Jun CD
J Cell Biochem; 2007 Dec; 102(6):1442-57. PubMed ID: 17471497
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling.
Liu P; He K; Song H; Ma Z; Yin W; Xu LX
J Inorg Biochem; 2016 Jul; 160():40-8. PubMed ID: 27138103
[TBL] [Abstract][Full Text] [Related]
12. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
Rossi NA; Mustafa I; Jackson JK; Burt HM; Horte SA; Scott MD; Kizhakkedathu JN
Biomaterials; 2009 Feb; 30(4):638-48. PubMed ID: 18977029
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
Bielski ER; Zhong Q; Brown M; da Rocha SR
Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species.
Im CN; Lee JS; Zheng Y; Seo JS
J Cell Biochem; 2007 Feb; 100(2):474-86. PubMed ID: 16927372
[TBL] [Abstract][Full Text] [Related]
15. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
16. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
Shvartsman M; Kikkeri R; Shanzer A; Cabantchik ZI
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1383-94. PubMed ID: 17670894
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice.
Wang S; Liu C; Pan S; Miao Q; Xue J; Xun J; Zhang Y; Gao Y; Duan X; Fan Y
Biochem Biophys Res Commun; 2015 Sep; 465(2):305-11. PubMed ID: 26277391
[TBL] [Abstract][Full Text] [Related]
18. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
19. Effect of the iron chelator desferrioxamine on manganese-induced toxicity of rat pheochromocytoma (PC12) cells.
Roth JA; Feng L; Dolan KG; Lis A; Garrick MD
J Neurosci Res; 2002 Apr; 68(1):76-83. PubMed ID: 11933051
[TBL] [Abstract][Full Text] [Related]
20. Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced neuroprotection: synthesis and in vitro evaluation.
Goswami D; Machini MT; Silvestre DM; Nomura CS; Esposito BP
Bioconjug Chem; 2014 Nov; 25(11):2067-80. PubMed ID: 25299707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
